Evidence map›Paper›PMID 36516161›Full record

ArticlePLoS genetics2022

Two distinct lipid transporters together regulate invasive filamentous growth in the human fungal pathogen Candida albicans.

Miguel A Basante-Bedoya, Stéphanie Bogliolo, Rocio Garcia-Rodas, Oscar Zaragoza, Robert A Arkowitz, Martine Bassilana

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Micafungin exposure drives multidrug resistance inbioRxiv : the preprint server for biology · 2026
    Article
  3. Insights intomSphere · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Regulation of yeast polarized exocytosis by phosphoinositide lipids.Cellular and molecular life sciences : CMLS · 2024
    Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Miguel A Basante-BedoyaUniversité Côte d'Azur, CNRS, INSERM, iBV, Parc Valrose, Nice, FRANCE.ORCID 0000-0002-2396-6399
Stéphanie BoglioloUniversité Côte d'Azur, CNRS, INSERM, iBV, Parc Valrose, Nice, FRANCE.
Rocio Garcia-RodasUniversité Côte d'Azur, CNRS, INSERM, iBV, Parc Valrose, Nice, FRANCE.
Oscar ZaragozaMycology Reference Laboratory, National Centre for Microbiology, Health Institute Carlos III, Majadahonda, Madrid, Spain.
Robert A ArkowitzUniversité Côte d'Azur, CNRS, INSERM, iBV, Parc Valrose, Nice, FRANCE.
Martine BassilanaUniversité Côte d'Azur, CNRS, INSERM, iBV, Parc Valrose, Nice, FRANCE.ORCID 0000-0001-9965-567X
Inserm · FRInstituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flippases transport lipids across the membrane bilayer to generate and maintain asymmetry. The human fungal pathogen Candida albicans has 5 flippases, including Drs2, which is critical for filamentous growth and phosphatidylserine (PS) distribution. Furthermore, a drs2 deletion mutant is hypersensitive to the antifungal drug fluconazole and copper ions. We show here that such a flippase mutant also has an altered distribution of phosphatidylinositol 4-phosphate [PI(4)P] and ergosterol. Analyses of additional lipid transporters, i.e. the flippases Dnf1-3, and all the oxysterol binding protein (Osh) family lipid transfer proteins, i.e. Osh2-4 and Osh7, indicate that they are not critical for filamentous growth. However, deletion of Osh4 alone, which exchanges PI(4)P for sterol, in a drs2 mutant can bypass the requirement for this flippase in invasive filamentous growth. In addition, deletion of the lipid phosphatase Sac1, which dephosphorylates PI(4)P, in a drs2 mutant results in a synthetic growth defect, suggesting that Drs2 and Sac1 function in parallel pathways. Together, our results indicate that a balance between the activities of two putative lipid transporters regulates invasive filamentous growth, via PI(4)P. In contrast, deletion of OSH4 in drs2 does not restore growth on fluconazole, nor on papuamide A, a toxin that binds PS in the outer leaflet of the plasma membrane, suggesting that Drs2 has additional role(s) in plasma membrane organization, independent of Osh4. As we show that C. albicans Drs2 localizes to different structures, including the Spitzenkörper, we investigated if a specific localization of Drs2 is critical for different functions, using a synthetic physical interaction approach to restrict/stabilize Drs2 at the Spitzenkörper. Our results suggest that the localization of Drs2 at the plasma membrane is critical for C. albicans growth on fluconazole and papuamide A, but not for invasive filamentous growth.

Indexed as

Candida albicansSaccharomyces cerevisiae ProteinsAdenosine TriphosphatasesFluconazoleFungal ProteinsHumansMembrane Transport ProteinsSaccharomyces cerevisiaeAdenosine TriphosphatasesFluconazoleFungal ProteinsMembrane Transport ProteinsSaccharomyces cerevisiae Proteins

Identifiers

PMID36516161
PMCPMC9797089
OpenAlexW4311438959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.